Hylvastam (Sodium Hydrogen Carbonate)

Hylvastam is used as an excipient to manage pH and stability in various intravenous and parenteral applications.

• Buffering in intravenous admixtures: helps maintain pH stability of IV solutions.
• pH adjustment in parenteral nutrition: provides appropriate alkalinity for nutrient compatibility.
• Stabilizer in vaccine formulations: supports antigen integrity during storage and administration.

• Sodium Hydrogen Carbonate dissociates in aqueous solution to release bicarbonate ions, which act as a physiological buffer. The bicarbonate system buffers hydrogen ions, thereby raising or stabilizing the pH of intravenous fluids. This buffering capacity helps maintain the desired acidity/alkalinity of parenteral preparations, ensuring chemical stability and compatibility with other components.

Adverse reactions may occur when sodium hydrogen carbonate is administered intravenously.

Common Side Effects

• Metabolic alkalosis: elevation of blood pH.
• Hypernatremia: increased serum sodium levels.
• Fluid overload: excess extracellular fluid volume.
• Hypokalemia: reduced serum potassium.
• Local irritation at infusion site.
• Transient hypertension.

Serious or Rare Side Effects

• Severe alkalosis leading to seizures.
• Cardiac arrhythmias, especially in patients with underlying heart disease.
• Pulmonary edema due to fluid shifts.
• Hypocalcemia causing tetany.
• Acute renal failure in susceptible individuals.
• Anaphylactic reaction to excipient components.

When using Hylvastam, consider the following safety measures.

• Dose adjustment: monitor serum electrolytes and acid‑base status.
• Renal function: assess kidney function before administration.
• Cardiac status: observe for arrhythmias in patients with heart disease.
• Acid‑base balance: avoid use in patients with existing metabolic alkalosis.
• Allergy: discontinue if hypersensitivity or anaphylaxis occurs.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Potential drug interactions should be reviewed prior to administration.

Major Interactions (Avoid)

• Concurrent calcium‑containing solutions: risk of precipitation.
• Co‑administration with other alkalinizing agents: may cause excessive alkalosis.
• Use with loop diuretics: can increase sodium load and affect electrolyte balance.

Moderate Interactions (Monitor Closely)

• Antihypertensive medications: monitor blood pressure for additive effects.
• Nephrotoxic drugs: observe renal function closely.
• Insulin therapy: watch for shifts in potassium levels.
• Anticoagulants: assess for changes in plasma pH that may affect drug activity.